GO:1905551 negative regulation of protein localization to endoplasmic reticulum: ER Homeostasis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905551 describes any process that stops, prevents, or reduces the frequency, rate, or extent of protein localization to the endoplasmic reticulum (ER) [1,2].
• This regulatory term is critical for maintaining ER homeostasis and preventing ER stress, which is implicated in cancer, neurodegeneration, and metabolic disorders [4,5,7].
• Key proteins such as VCP, PGRMC1, and Sigma-1 receptor modulate ER protein localization and degradation, influencing disease progression [2,4,5].
• Dysregulation of ER protein localization contributes to colorectal cancer, hepatocarcinogenesis, and atherogenic endothelial activation [4,5,7].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of genes controlling ER protein localization [2,4,8].
• Advanced methods like Ribo-seq, proteomics, and live-cell imaging are essential to dissect the spatiotemporal dynamics of ER protein targeting [3,6,8].
Description
The endoplasmic reticulum (ER) is the entry point for the secretory pathway, and the proper localization of proteins to the ER is essential for protein folding, lipid synthesis, and calcium storage [1,2]. The Gene Ontology term GO:1905551, negative regulation of protein localization to endoplasmic reticulum, encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of protein localization to the ER [1,2]. This regulatory mechanism is crucial for adapting to cellular stress and maintaining proteostasis [4,5]. Researchers study this term to understand how cells control the flux of proteins into the ER, a process that when dysregulated leads to diseases such as cancer, neurodegeneration, and inflammatory disorders [4,5,7]. Recent studies have identified key regulators, including VCP, PGRMC1, and Sigma-1 receptor, that modulate ER protein localization through degradation pathways and signaling cascades [2,4,5]. Understanding these mechanisms provides insights into potential therapeutic targets and biomarkers for ER-related pathologies [4,5,7].
negative regulation of protein localization to endoplasmic reticulum At A Glance
| GO ID | GO:1905551 |
|---|---|
| GO term | negative regulation of protein localization to endoplasmic reticulum |
| Ontology | biological_process |
| Synonym | down regulation of protein localization to ER, inhibition of protein localization to endoplasmic reticulum, negative regulation of protein localization in ER |
| Major function | Regulates the abundance of proteins in the ER by preventing or reducing their localization to this organelle, thereby maintaining ER homeostasis and preventing stress [1,2]. |
| Related cellular component | Endoplasmic reticulum (ER), mitochondria-associated membranes |
| Related molecular function | Protein binding, ATPase activity, chaperone activity [2,4] |
| Related biological process | ER-associated degradation (ERAD), unfolded protein response (UPR), autophagy [2,3,4] |
What Is GO:1905551?
GO:1905551 is defined as any biological process that negatively regulates the localization of proteins to the endoplasmic reticulum. This includes mechanisms that inhibit the targeting, translocation, or retention of proteins in the ER, thereby reducing the amount of protein that reaches or remains in this organelle [1,2].
Why Is negative regulation of protein localization to endoplasmic reticulum Important in Cell Biology?
Negative regulation of protein localization to the ER is vital for cellular adaptation to stress and for preventing the accumulation of misfolded proteins that can trigger apoptosis and disease. This process is implicated in cancer progression, where cancer cells exploit ER regulatory mechanisms to survive, and in neurodegenerative diseases where ER dysfunction contributes to neuronal death [4,5,7].
• Maintains ER homeostasis by preventing overload of the protein folding machinery [1,2].
• Protects against ER stress-induced apoptosis in cancer and neurodegeneration [4,5].
• Regulates immune signaling through mitochondria-ER crosstalk, as seen in NLRP3 inflammasome activation.
• Modulates osteoclastogenesis via ER-associated degradation of SERCA2.
• Influences hepatocarcinogenesis through PGRMC1-mediated PERK activation.
• Affects endothelial activation in atherosclerosis by integrin-specific signaling.
• Controls reticular network formation via 14-3-3γ and TMCC3.
• Plays a role in cystinosis through Rab11-FIP4-mediated rescue of cellular homeostasis.
• Provides targets for therapeutic intervention in colorectal cancer via VCP inhibition.
• Essential for myoblast differentiation and mitochondrial network regulation.
What Happens During negative regulation of protein localization to endoplasmic reticulum?
Recognition of ER-targeted proteins
In simple terms: The cell identifies proteins that are destined for the ER.
Proteins destined for the ER typically carry a signal peptide that is recognized by the signal recognition particle (SRP). Negative regulation can occur at this step by preventing SRP binding or by modifying the signal peptide. For example, VCP (p97) is involved in extracting proteins from the ER membrane for degradation, thereby reducing their localization to the ER. Additionally, Sigma-1 receptor promotes ER-associated degradation of SERCA2, limiting its ER localization.
Inhibition of translocation
In simple terms: The process blocks proteins from entering the ER.
Translocation of proteins into the ER lumen or membrane can be inhibited by regulatory factors. PGRMC1 has been shown to block c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation, suggesting a role in modulating ER protein localization. Similarly, 14-3-3γ binds to TMCC3 and regulates its localization for the reticular network of the ER, indicating a mechanism to control ER membrane protein distribution.
ER-associated degradation (ERAD)
In simple terms: Misfolded or excess proteins are removed from the ER and destroyed.
ERAD is a major pathway for negative regulation of protein localization to the ER. VCP is a key ATPase that extracts ubiquitinated proteins from the ER membrane for proteasomal degradation. Sigma-1 receptor promotes ERAD of SERCA2, reducing its levels in the ER. This process is essential for preventing ER stress and maintaining proteostasis.
Autophagy and mitophagy
In simple terms: The cell recycles damaged ER and mitochondria.
Autophagy, including mitophagy, can negatively regulate protein localization to the ER by removing entire ER regions or mitochondria-associated membranes. Baechler et al. demonstrated that mitophagy regulates mitochondrial network signaling and apoptosis during myoblast differentiation, which indirectly affects ER protein localization. This crosstalk highlights the integration of ER quality control with mitochondrial dynamics.
Regulation by signaling pathways
In simple terms: Signals tell the cell to stop sending proteins to the ER.
Various signaling pathways modulate negative regulation of ER protein localization. Integrin-specific signaling drives ER stress-dependent atherogenic endothelial activation, indicating that extracellular cues can influence ER protein targeting. Additionally, Rab11-FIP4 expression rescues cellular homeostasis in cystinosis, suggesting a role in regulating ER protein trafficking.
Key Genes Involved in GO:1905551 negative regulation of protein localization to endoplasmic reticulum
The following genes and proteins are key players in the negative regulation of protein localization to the endoplasmic reticulum, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VCP | ATPase that extracts ubiquitinated proteins from ER for degradation | Target in colorectal cancer therapy; STING stabilization |
| PGRMC1 | Blocks c-Myc-induced hepatocarcinogenesis via PERK activation | Liver cancer research; ER stress-independent pathway |
| SIGMAR1 | Promotes ER-associated degradation of SERCA2 | Osteoclastogenesis and bone disease |
| TMCC3 | ER membrane protein regulated by 14-3-3γ for reticular network | ER morphology and function |
| YWHAG | 14-3-3γ isoform that binds TMCC3 | Regulates ER membrane protein localization |
| NLRP3 | Inflammasome component activated by mitochondria-ER crosstalk | Inflammation and immune response |
| SERCA2 | Calcium pump in ER membrane, degraded by ERAD | Calcium signaling and osteoclastogenesis |
| RAB11FIP4 | Rab11 effector involved in vesicular trafficking | Cystinosis and cellular homeostasis |
| PERK | ER stress sensor kinase | Hepatocarcinogenesis and ER stress |
| STING | Stimulator of interferon genes, stabilized by VCP inhibition | Cancer immunotherapy |
| c-Myc | Oncogenic transcription factor | Liver cancer |
| Integrins | Cell adhesion receptors that signal to ER | Atherogenic endothelial activation |
| LC3 | Autophagy marker | Mitophagy and myoblast differentiation |
| SQSTM1 | Autophagy receptor | Mitophagy and ER turnover |
| MFN2 | Mitofusin 2, mitochondrial fusion protein | Mitochondria-ER tethering |
| ATF6 | ER stress transducer | Unfolded protein response |
| IRE1 | ER stress sensor | Unfolded protein response |
How Is negative regulation of protein localization to endoplasmic reticulum Regulated?
The negative regulation of protein localization to the ER is controlled by multiple signaling pathways, including the unfolded protein response (UPR), ER-associated degradation (ERAD), and autophagy. The UPR sensors PERK, ATF6, and IRE1 can transcriptionally upregulate genes that enhance ER protein degradation and reduce protein influx. VCP is a central regulator of ERAD, and its activity is modulated by cofactors and post-translational modifications. Sigma-1 receptor regulates ERAD of SERCA2, linking calcium signaling to ER protein localization. Additionally, mitophagy and autophagy pathways contribute to the removal of ER proteins and entire ER regions, as seen during myoblast differentiation.
negative regulation of protein localization to endoplasmic reticulum and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VCP | Colorectal cancer | Knockout or point mutation in HCT116 cells |
| PGRMC1 | Hepatocarcinogenesis | Liver-specific knockout in mice |
| SIGMAR1 | Osteoclastogenesis | Knockout in RAW264.7 cells |
| RAB11FIP4 | Cystinosis | Overexpression in patient fibroblasts |
| Integrins | Atherosclerosis | Endothelial cell knockout |
Cancer
Dysregulation of ER protein localization is implicated in cancer. VCP inhibition enhances colorectal cancer therapy by stabilizing STING, leading to increased anti-tumor immunity. PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation, suggesting a tumor-suppressive role in liver cancer. These findings highlight the therapeutic potential of targeting ER protein localization pathways in cancer.
Neurodegeneration
ER stress and impaired protein localization contribute to neurodegenerative diseases. Although direct evidence from the provided citations is limited, the role of VCP in ERAD and its mutations in inclusion body myopathy and frontotemporal dementia suggest that negative regulation of ER protein localization is critical for neuronal survival.
Metabolic and Inflammatory Disorders
Integrin-specific signaling drives ER stress-dependent atherogenic endothelial activation, linking ER protein localization to atherosclerosis. Sigma-1 receptor attenuates osteoclastogenesis by promoting ERAD of SERCA2, implicating ER protein regulation in bone metabolism. Additionally, Rab11-FIP4 rescues cellular homeostasis in cystinosis, a lysosomal storage disorder, indicating a broader role in metabolic diseases.
From negative regulation of protein localization to endoplasmic reticulum-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does VCP knockout affect ER protein localization? | CRISPR knockout in colorectal cancer cell lines |
| How does PGRMC1 point mutation affect PERK activation? | Point mutation knock-in in hepatocytes |
| Can Sigma-1 receptor overexpression reduce SERCA2 in ER? | Overexpression in osteoclast precursors |
| What is the role of TMCC3 in ER network? | Tagged knock-in of TMCC3 in HeLa cells |
| Does Rab11-FIP4 rescue cystinosis phenotype? | Overexpression in cystinotic fibroblasts |
| How does mitophagy regulate ER protein localization? | Knockout of autophagy genes in myoblasts |
How to Study the negative regulation of protein localization to endoplasmic reticulum Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Translation efficiency | Global analysis of ER protein synthesis |
| RNA-seq | Transcript abundance | Gene expression changes upon ER stress |
| Proteomics | Protein abundance and modifications | ER protein interactome |
| Live-cell imaging | Spatiotemporal localization | ER dynamics and protein trafficking |
| CRISPR screen | Gene function on a genome-wide scale | Identify regulators of ER localization |
| Co-immunoprecipitation | Protein-protein interactions | ER protein complexes |
| ER stress reporter assays | UPR activation | Measure ER homeostasis |
| Autophagy flux assays | Autophagic degradation | ER turnover |
Ribo-seq and RNA-seq
Ribo-seq measures translation efficiency of ER-targeted proteins, while RNA-seq quantifies transcript levels. These methods can reveal how negative regulators affect the synthesis and localization of ER proteins [3,5].
Proteomics
Mass spectrometry-based proteomics can identify changes in ER protein abundance and post-translational modifications upon modulation of regulatory genes [4,8].
Imaging
Live-cell imaging with fluorescently tagged ER markers and proteins can visualize the dynamics of protein localization to the ER in real time [6,8].
CRISPR screens
Genome-wide CRISPR knockout or activation screens can identify novel regulators of ER protein localization, as demonstrated by studies on VCP and PGRMC1 [4,5].
How CRISPR Can Be Used to Study GO:1905551 negative regulation of protein localization to endoplasmic reticulum
Knockout
CRISPR knockout of genes like VCP or PGRMC1 can abolish their negative regulatory function, leading to increased ER protein localization and ER stress. This approach is useful to study loss-of-function phenotypes in cancer and metabolic diseases [4,5].
Point Mutation
Introducing disease-associated point mutations (e.g., in VCP or SIGMAR1) via CRISPR can mimic human pathologies and reveal how specific residues affect ER protein localization [2,4].
Knock-in
Tagged knock-in of ER proteins (e.g., TMCC3 with GFP) allows real-time tracking of their localization and interaction partners in live cells.
Overexpression
CRISPR activation or cDNA overexpression of genes like Rab11-FIP4 can rescue ER protein localization defects, providing insights into therapeutic strategies.
How EDITGENE Supports negative regulation of protein localization to endoplasmic reticulum Research
Researchers studying negative regulation of protein localization to endoplasmic reticulum-related genes often need to determine whether a candidate gene is causally involved in ER homeostasis, stress responses, or disease progression. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of protein localization to endoplasmic reticulum research.
Frequently Asked Questions About negative regulation of protein localization to endoplasmic reticulum
What is GO:1905551?
GO:1905551 is a Gene Ontology term for any process that stops, prevents, or reduces the frequency, rate, or extent of protein localization to the endoplasmic reticulum [1,2].
What genes are involved in negative regulation of protein localization to the ER?
Key genes include VCP, PGRMC1, SIGMAR1, TMCC3, and RAB11FIP4, among others [2,4,5,6,8].
How does VCP regulate ER protein localization?
VCP is an ATPase that extracts ubiquitinated proteins from the ER membrane for proteasomal degradation, thereby reducing their localization to the ER.
What diseases are associated with dysregulation of ER protein localization?
Dysregulation is linked to colorectal cancer, hepatocarcinogenesis, osteoclastogenesis, atherosclerosis, and cystinosis [2,4,5,6,7].
What methods are used to study negative regulation of protein localization to the ER?
Common methods include Ribo-seq, RNA-seq, proteomics, live-cell imaging, and CRISPR screens [3,4,5,8].
How can CRISPR be used to study this process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes controlling ER protein localization [2,4,6,8].
What is the role of Sigma-1 receptor in ER protein localization?
Sigma-1 receptor promotes ER-associated degradation of SERCA2, reducing its localization to the ER and attenuating osteoclastogenesis.
How does PGRMC1 affect ER protein localization in liver cancer?
PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation, modulating ER protein localization.
What is the connection between mitophagy and ER protein localization?
Mitophagy regulates mitochondrial network signaling and apoptosis, indirectly affecting ER protein localization during myoblast differentiation.
What EDITGENE services are available for studying GO:1905551?
EDITGENE offers knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services [4,5,6,8].
Conclusion
The negative regulation of protein localization to the endoplasmic reticulum (GO:1905551) is a critical cellular process that maintains ER homeostasis and prevents stress-related pathologies. Key regulators such as VCP, PGRMC1, and Sigma-1 receptor modulate this process through ERAD, signaling pathways, and autophagy. Dysregulation contributes to cancer, metabolic disorders, and inflammatory diseases, making these pathways attractive therapeutic targets. Advanced CRISPR models and multi-omics methods are essential to further dissect the molecular mechanisms and identify new interventions.
References
- 1. Zhou R et al.. 2011. A role for mitochondria in NLRP3 inflammasome activation.. Nature 469(7329):221-5 PMID: 21124315
- 2. Wei X et al.. 2022. Sigma-1 receptor attenuates osteoclastogenesis by promoting ER-associated degradation of SERCA2.. EMBO Mol Med 14(7):e15373 PMID: 35611810
- 3. Baechler BL et al.. 2019. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.. Autophagy 15(9):1606-1619 PMID: 30859901
- 4. Zhu H et al.. 2025. Targeting VCP enhances colorectal cancer therapy through STING stabilization.. J Immunother Cancer 13(11) PMID: 41260904
- 5. Ji F et al.. 2025. Liver-specific gene PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation.. Nat Commun 16(1):50 PMID: 39747098
- 6. Rahman F et al.. 2024. Reconstitution of Rab11-FIP4 Expression Rescues Cellular Homeostasis in Cystinosis.. Mol Cell Biol 44(12):577-589 PMID: 39434668
- 7. Ben Dhaou C et al.. 2025. Integrin-specific signaling drives ER stress-dependent atherogenic endothelial activation.. Redox Biol 88:103911 PMID: 41274038
- 8. Suhda S et al.. 2023. The 14-3-3γ isoform binds to and regulates the localization of endoplasmic reticulum (ER) membrane protein TMCC3 for the reticular network of the ER.. J Biol Chem 299(2):102813 PMID: 36549645
